IMVT Other Income/Expenses (Net)

Immunovant Inc · Other Income/Expenses (Net)

IMVT logo

IMVT Other Income/Expenses (Net)

Latest reported$19.99M
IMVT TTM Other Income/Expenses (Net) ($869.70K → $19.99M)
High-resolution chart · PNG

IMVT other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunovant Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
19,991,000
27,511,000
26,616,000
24,669,000
25,517,000
25,201,000
23,034,000
29,729,000
26,619,000
11,440,000
9,484,000
-9,356,000
-11,001,000
-2,676,000
-6,468,000
2,231,000
200,000
-780,000
-144,000
-533,000
-224,000
328,000
-479,000
-131,000
327,140
742,698
869,698
1,067,644
278,421
-63,146
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.